Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Experts Will Vote on a Cure for Sickle Cell Disease

The treatment from the company Vertex would be the first medicine to use the gene editing tool CRISPR.

Gina Kolata
Author: Gina Kolata

Written by

Gina Kolata

in

Crispr (DNA), CRISPR Therapeutics, Drugs (Pharmaceuticals), Food and Drug Administration, Genetic Engineering, Sickle Cell Anemia, Therapy and Rehabilitation, Vertex Pharmaceuticals Inc
←Ex-North Dakota Lawmaker Accused Of Flying To Prague To Rape Minor
X Says It Is Worth $19 Billion, Down From $44 Billion Last Year→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube